Nykode Therapeutics AS (OSL: NYKD)

Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	136.53	162.6	206.39	216.23	183.85	10.17
Trading Asset Securities	-	-	-	12.17	24.94	21.68
Cash & Short-Term Investments	136.53	162.6	206.39	228.4	208.8	31.85
Cash Growth	-21.34%	-21.21%	-9.64%	9.39%	555.64%	-77.82%
Accounts Receivable	-	-	2.54	23.75	18.75	0
Other Receivables	3.49	1.07	1.79	2.41	1.34	1.26
Receivables	3.49	1.07	4.33	26.16	20.09	1.26
Prepaid Expenses	-	2.01	1.15	1.3	0.15	0.07
Other Current Assets	-	-	-	-	-0	0
Total Current Assets	140.02	165.68	211.87	255.86	229.03	33.17
Property, Plant & Equipment	9.28	10.52	9.53	9.17	0.41	0.17
Other Intangible Assets	0.07	0.07	0.03	0.03	0.03	0.03
Long-Term Deferred Charges	-	-	-	0.48	0.55	-
Other Long-Term Assets	30.5	31.92	0.05	0.02	0.01	0.01
Total Assets	179.88	208.19	221.48	265.56	230.03	33.39
Accounts Payable	3.42	1.33	2.31	2.75	1.61	1.52
Accrued Expenses	-	6.08	7.58	9.3	9.68	2.47
Current Portion of Leases	1.4	1.46	1.15	1.35	0.28	0.06
Current Income Taxes Payable	-	-	0.08	0.03	-	-
Current Unearned Revenue	7.29	8.34	19.87	16.26	-	0.09
Other Current Liabilities	2.99	3.41	8	1.69	1.61	0.18
Total Current Liabilities	15.09	20.61	38.99	31.37	13.18	4.32
Long-Term Leases	3.39	4.27	4.37	5.82	0.01	0.03
Long-Term Deferred Tax Liabilities	8.44	12.05	21.08	29.4	31.13	-
Other Long-Term Liabilities	0.88	0	0.03	4.91	6.86	1.4
Total Liabilities	27.8	36.93	64.46	71.5	51.18	5.76
Common Stock	0.37	0.37	0.34	0.33	0.33	0.32
Additional Paid-In Capital	128.99	128.99	83.32	81.53	60.35	59.13
Retained Earnings	7.73	29.56	64.71	107.46	116.87	-32.91
Comprensive Income & Other	15	12.35	8.65	4.74	1.31	1.09
Shareholders' Equity	152.08	171.26	157.02	194.06	178.85	27.63
Total Liabilities & Equity	179.88	208.19	221.48	265.56	230.03	33.39
Total Debt	4.79	5.73	5.51	7.17	0.28	0.09
Net Cash (Debt)	131.75	156.88	200.87	221.23	208.51	31.76
Net Cash Growth	-21.35%	-21.90%	-9.20%	6.10%	556.60%	-77.89%
Net Cash Per Share	0.41	0.52	0.69	0.77	0.70	0.11
Filing Date Shares Outstanding	326.55	326.55	294.69	289.62	284.79	274.87
Total Common Shares Outstanding	326.55	326.55	294.69	289.62	284.79	274.87
Working Capital	124.93	145.07	172.89	224.49	215.85	28.86
Book Value Per Share	0.47	0.52	0.53	0.67	0.63	0.10
Tangible Book Value	152.01	171.19	156.99	194.02	178.82	27.6
Tangible Book Value Per Share	0.47	0.52	0.53	0.67	0.63	0.10
Machinery	-	4.97	3.44	1.46	0.2	0.12

Source: S&P Capital IQ. Standard template. Financial Sources.